Bleeding risk in patients undergoing percutaneous coronary intervention : how to define, identify and treat high-risk patients
A significant proportion of patients undergoing percutaneous coronary intervention (PCI) is deemed at high bleeding risk. Definition and identification of high bleeding risk patients at the time of PCI is extremely important to inform decision-making regarding antithrombotic treatment selection and optimize the balance between ischemic and bleeding risk. The recent introduction of standardized definitions and tools to identify and treat patients at high bleeding risk is promising to improve evidence-based care in this subgroup of patients.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
|---|---|
| Enthalten in: |
Giornale italiano di cardiologia (2006) - 21(2020), 2 Suppl 1 vom: 29. Feb., Seite 5S-13S |
| Sprache: |
Italienisch |
|---|
| Weiterer Titel: |
Il rischio emorragico nei pazienti candidati ad angioplastica coronarica: come definire, identificare e trattare i pazienti ad alto rischio |
|---|
| Beteiligte Personen: |
Fimiani, Luigi [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 19.11.2020 Date Revised 19.11.2020 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1714/3311.32816 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM307254186 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM307254186 | ||
| 003 | DE-627 | ||
| 005 | 20231225125149.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||ita c | ||
| 024 | 7 | |a 10.1714/3311.32816 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1024.xml |
| 035 | |a (DE-627)NLM307254186 | ||
| 035 | |a (NLM)32134403 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ita | ||
| 100 | 1 | |a Fimiani, Luigi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Bleeding risk in patients undergoing percutaneous coronary intervention |b how to define, identify and treat high-risk patients |
| 246 | 3 | 3 | |a Il rischio emorragico nei pazienti candidati ad angioplastica coronarica: come definire, identificare e trattare i pazienti ad alto rischio |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.11.2020 | ||
| 500 | |a Date Revised 19.11.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a A significant proportion of patients undergoing percutaneous coronary intervention (PCI) is deemed at high bleeding risk. Definition and identification of high bleeding risk patients at the time of PCI is extremely important to inform decision-making regarding antithrombotic treatment selection and optimize the balance between ischemic and bleeding risk. The recent introduction of standardized definitions and tools to identify and treat patients at high bleeding risk is promising to improve evidence-based care in this subgroup of patients | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 7 | |a Fibrinolytic Agents |2 NLM | |
| 700 | 1 | |a Laterra, Giulia |e verfasserin |4 aut | |
| 700 | 1 | |a Caracciolo, Alessandro |e verfasserin |4 aut | |
| 700 | 1 | |a Cerrato, Enrico |e verfasserin |4 aut | |
| 700 | 1 | |a D'Ascenzo, Fabrizio |e verfasserin |4 aut | |
| 700 | 1 | |a Piccolo, Raffaele |e verfasserin |4 aut | |
| 700 | 1 | |a Capodanno, Davide |e verfasserin |4 aut | |
| 700 | 1 | |a Costa, Francesco |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Giornale italiano di cardiologia (2006) |d 2006 |g 21(2020), 2 Suppl 1 vom: 29. Feb., Seite 5S-13S |w (DE-627)NLM16119561X |x 1972-6481 |7 nnns |
| 773 | 1 | 8 | |g volume:21 |g year:2020 |g number:2 Suppl 1 |g day:29 |g month:02 |g pages:5S-13S |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1714/3311.32816 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 21 |j 2020 |e 2 Suppl 1 |b 29 |c 02 |h 5S-13S | ||